Iovance Biotherapeutics I...

3.49
0.24 (7.38%)
At close: Apr 02, 2025, 11:00 AM

Iovance Biotherapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2023Jun 30, 2023
Product Revenue 500K 200K
Product Revenue Growth +150.00% n/a

Revenue by Geography

Quarter Dec 31, 2023
Non-Us Revenue 1.2M
Non-Us Revenue Growth n/a
United States Revenue n/a
United States Revenue Growth n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 39.55M 34.19M 26.12M 20.19M 26.96M 21.93M 28.12M 26.46M 27.89M 26.33M 23.41M 23.85M 20.89M 19.31M 19.62M 16.08M 15.92M 14.35M 13.86M 10.87M 10.03M 10.87M 9.08M 7.53M 7.11M 6.83M 6.96M 5.38M 4.59M 3.93M 4.26M 5.02M 10.5M 7.26M 2.82M 3.93M 2.66M 2.38M 3.29M
Selling, General, and Administrative Revenue Growth +15.69% +30.90% +29.37% -25.13% +22.97% -22.03% +6.27% -5.13% +5.94% +12.45% -1.83% +14.18% +8.18% -1.60% +22.00% +1.05% +10.89% +3.57% +27.47% +8.41% -7.71% +19.67% +20.68% +5.79% +4.19% -1.98% +29.58% +17.10% +16.85% -7.77% -15.19% -52.16% +44.52% +157.77% -28.24% +47.63% +11.55% -27.46% n/a
Research and Development Revenue 68.25M 62.08M 79.78M 87.47M 87.53M 86.35M 82.73M 80.57M 72.5M 73.41M 68.3M 75.62M 65.36M 62.12M 55.95M 52.45M 43.05M 49.27M 56.95M 54.24M 41.58M 39.3M 30.91M 27.42M 27.95M 24.55M 19.91M 20.7M 17.75M 19.65M 16.62M 10.9M 8.48M 4.46M 4.19M 5.11M 4.98M 4.06M 2.01M
Research and Development Revenue Growth +9.92% -22.18% -8.79% -0.06% +1.37% +4.37% +2.68% +11.13% -1.23% +7.48% -9.68% +15.70% +5.21% +11.03% +6.67% +21.84% -12.63% -13.48% +5.00% +30.44% +5.81% +27.16% +12.72% -1.89% +13.83% +23.30% -3.79% +16.58% -9.67% +18.23% +52.49% +28.53% +90.03% +6.46% -17.92% +2.49% +22.86% +101.67% n/a